MICROENCAPSULATION OF ASTAXANTHIN IN ALGINATE USING MODIFIED EMULSION TECHNOLOGY: PREPARATION, CHARACTERIZATION, AND CYTOSTATIC ACTIVITY

被引:29
作者
Zhang, Xiujuan [1 ]
Yin, Wenjuan [1 ]
Qi, Yankai [1 ]
Li, Xiangcun [2 ]
Zhang, Wenjun [1 ]
He, Gaohong [1 ,2 ]
机构
[1] Dalian Univ Technol, Sch Petr & Chem Engn, State Key Lab Fine Chem, Panjin 124221, Peoples R China
[2] Dalian Univ Technol, Sch Chem Engn, R&D Ctr Membrane Sci & Technol, Dalian 116024, Peoples R China
基金
中国国家自然科学基金;
关键词
astaxanthin; calcium alginate; encapsulation efficiency; uniform size distribution; cytostatic activity; CHITOSAN-CARRAGEENAN NANOPARTICLES; HAEMATOCOCCUS-PLUVIALIS; TRANS-ASTAXANTHIN; DRUG-RELEASE; HUMAN HEALTH; ENCAPSULATION; DELIVERY; ANTIOXIDANT; STABILITY; ERYTHROPOIETIN;
D O I
10.1002/cjce.22712
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
In the present study, astaxanthin was microencapsulated in a biodegradable material, calcium alginate, using a modified emulsion technology developed at our laboratory. The modified emulsion method involves the reaction between a sodium alginate emulsion and a calcium chloride emulsion. After mixing these emulsions, Ca2+ penetrates two oil-water layers to combine -COO-, and microparticles are formed with narrow size distribution and good dispersion due to the mild reaction speed. The microencapsulated astaxanthin showed much higher storage stability and antioxidant activity than the non-encapsulated astaxanthin. Cytostatic activity was preliminarily evaluated on adipose-derived stem cells, the microencapsulated astaxanthin showed significant cytostatic activity due to the improved solubility of astaxanthin caused by the good biocompatibility of calcium alginate. Characterization confirmed the existence of microparticles with high encapsulation efficiency (more than 85%), uniform size distribution (1.61 mu m), and sustained astaxanthin release, suggesting the prepared microparticles by the modified emulsion method have great potential in pharmaceutical, food, and cosmetic industries.
引用
收藏
页码:412 / 419
页数:8
相关论文
共 35 条
[1]   Erythropoietin Encapsulation in Chitosan Nanoparticles and Kinetics of Drug Release [J].
Bokharaei, M. ;
Margaritis, A. ;
Xenocostas, A. ;
Freeman, D. J. .
CURRENT DRUG DELIVERY, 2011, 8 (02) :164-171
[2]   Encapsulation and Controlled Release of Recombinant Human Erythropoietin from Chitosan-Carrageenan Nanoparticles [J].
Bulmer, Cody ;
Margaritis, Argyrios ;
Xenocostas, Anargyros .
CURRENT DRUG DELIVERY, 2012, 9 (05) :527-537
[3]   Characterization of Novel Composite Alginate Chitosan-Carrageenan Nanoparticles for Encapsulation of BSA as a Model Drug Delivery System [J].
Cheng, Landi ;
Bulmer, Cody ;
Margaritis, Argyrios .
CURRENT DRUG DELIVERY, 2015, 12 (03) :351-357
[4]   Astaxanthin production by Phaffia rhodozyma and Haematococcus pluvialis:: a comparative study [J].
Dominguez-Bocanegra, A. R. ;
Ponce-Noyola, T. ;
Torres-Munoz, J. A. .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2007, 75 (04) :783-791
[5]   SORPTION AND TRANSPORT IN GLASSY-POLYMERS - REVIEW [J].
FRISCH, HL .
POLYMER ENGINEERING AND SCIENCE, 1980, 20 (01) :2-13
[6]   Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan - a review [J].
George, Meera ;
Abraham, T. Emilia .
JOURNAL OF CONTROLLED RELEASE, 2006, 114 (01) :1-14
[7]   Haematococcus astaxanthin:: applications for human health and nutrition [J].
Guerin, M ;
Huntley, ME ;
Olaizola, M .
TRENDS IN BIOTECHNOLOGY, 2003, 21 (05) :210-216
[8]   Astaxanthin:: A review of its chemistry and applications [J].
Higuera-Ciapara, I ;
Félix-Valenzuela, L ;
Goycoolea, FM .
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2006, 46 (02) :185-196
[9]   Microencapsulation of astaxanthin in a chitosan matrix [J].
Higuera-Ciapara, I ;
Felix-Valenzuela, L ;
Goycoolea, FM ;
Argüelles-Monal, W .
CARBOHYDRATE POLYMERS, 2004, 56 (01) :41-45
[10]   Astaxanthin, a carotenoid with potential in human health and nutrition [J].
Hussein, G ;
Sankawa, U ;
Goto, H ;
Matsumoto, K ;
Watanabe, H .
JOURNAL OF NATURAL PRODUCTS, 2006, 69 (03) :443-449